GB201200858D0 - Prebiotic powder composition and uses thereof - Google Patents
Prebiotic powder composition and uses thereofInfo
- Publication number
- GB201200858D0 GB201200858D0 GBGB1200858.7A GB201200858A GB201200858D0 GB 201200858 D0 GB201200858 D0 GB 201200858D0 GB 201200858 A GB201200858 A GB 201200858A GB 201200858 D0 GB201200858 D0 GB 201200858D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- powder composition
- skin
- composition
- prebiotic
- prebiotic powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000000843 powder Substances 0.000 title abstract 3
- 235000013406 prebiotics Nutrition 0.000 title abstract 2
- 229920001202 Inulin Polymers 0.000 abstract 1
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A powdered composition for application to the surface of the skin, characterised in that the powder comprises at least one prebiotic, for example inulin and/or alpha glucan oligosaccharide. The composition may be used to stimulate the growth of beneficial microorganisms on the surface of the skin, more preferably, in the treatment or prevention of aberrant infection of the skin or for use as a cosmetic. Also disclosed is a method for producing such a powder composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1200858.7A GB2498543A (en) | 2012-01-19 | 2012-01-19 | Topical prebiotic powder composition and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1200858.7A GB2498543A (en) | 2012-01-19 | 2012-01-19 | Topical prebiotic powder composition and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201200858D0 true GB201200858D0 (en) | 2012-02-29 |
| GB2498543A GB2498543A (en) | 2013-07-24 |
Family
ID=45814209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1200858.7A Withdrawn GB2498543A (en) | 2012-01-19 | 2012-01-19 | Topical prebiotic powder composition and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2498543A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110755345A (en) * | 2019-10-30 | 2020-02-07 | 植物医生(广东)生物科技有限公司 | Prebiotic composition and application thereof |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITTO20130770A1 (en) * | 2013-09-25 | 2015-03-26 | Paglieri S P A | COMPOSITION BASED ON ACTIVE PREBIOTIC PRINCIPLES FOR THE FORMULATION OF COSMETIC PRODUCTS. |
| GB201320409D0 (en) | 2013-11-19 | 2014-01-01 | Univ Aberystwyth | Prebiotic composition |
| MX2018013865A (en) * | 2016-05-12 | 2019-07-18 | Natura Cosmeticos Sa | Probiotic cosmetic compositions and use of the probiotic cosmetic compositions. |
| FR3081709B1 (en) * | 2018-05-29 | 2020-10-09 | Lilas 3 | STERILE TOPICAL COMPOSITION FOR USE IN NEWBORNS TO MAINTAIN, REGULATE AND NORMALIZE THE SKIN MICROBIOTE |
| WO2020229446A1 (en) * | 2019-05-16 | 2020-11-19 | Unilever N.V. | Use of a sugar or sugar alcohol |
| FR3104025B1 (en) * | 2019-12-04 | 2021-12-10 | Yodi Sas | New cosmetic compositions |
| CA3160196A1 (en) * | 2019-12-04 | 2021-06-10 | Helene Azancot | Cosmetic cleaning compositions in powder form |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2933617B1 (en) * | 2008-07-10 | 2010-09-17 | Alliospharma | COMPOSITIONS FOR PROMOTING THE DEVELOPMENT AND GROWTH OF A BENEFICIAL VAGINAL MICROFLORE |
-
2012
- 2012-01-19 GB GB1200858.7A patent/GB2498543A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110755345A (en) * | 2019-10-30 | 2020-02-07 | 植物医生(广东)生物科技有限公司 | Prebiotic composition and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2498543A (en) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201200858D0 (en) | Prebiotic powder composition and uses thereof | |
| WO2012112777A3 (en) | Biosynthesis of human milk oligosaccharides in engineered bacteria | |
| PH12018501221A1 (en) | Mixture of hmos | |
| PH12020500352A1 (en) | Therapeutic uses of empagliflozin | |
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| PH12016500762A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
| MX2010003258A (en) | Use of a novel natural agent in cosmetic compositions. | |
| ZA201701460B (en) | Gamma-diketones for treatment and prevention of aging skin and wrinkles | |
| TN2012000549A1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
| MX2015009037A (en) | Honey nasal rinse. | |
| MX2018004616A (en) | Cosmetic composition having probiotic bacteria. | |
| MX2016014807A (en) | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides. | |
| MX2015002177A (en) | 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections. | |
| UA109876C2 (en) | Composition containing bifidobacterium longum cncm i-2618 for use in treatment or prevention of disorders related to immune system | |
| MX2011009539A (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof. | |
| MX359626B (en) | Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction. | |
| WO2015058664A8 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
| MX2020013740A (en) | Therapeutic uses of empagliflozin. | |
| HK1221171A1 (en) | Compositions for use in stimulating bone growth | |
| NZ630367A (en) | Methods of treatment of pediatric solid tumor | |
| MX342947B (en) | Treatment of type 2 diabetes. | |
| NZ715595A (en) | Treatment of disease with poly-n-acetyglucosamine nanofibers | |
| TN2015000255A1 (en) | Chitin or derivatives thereof for the prevention and/or treatment of parasitoses | |
| WO2015084883A3 (en) | Compositions and methods for treating osteoarthritis | |
| GB2549400A (en) | Creped prebiotic tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |